| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8676 |
| Human Intestinal Absorption | HIA+ | 0.7155 |
| Caco-2 Permeability | Caco2- | 0.6076 |
| P-glycoprotein Substrate | Non-substrate | 0.6461 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8825 |
| Non-inhibitor | 0.9859 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8965 |
| Distribution |
| Subcellular localization | Lysosome | 0.4076 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7856 |
| CYP450 2D6 Substrate | Non-substrate | 0.7728 |
| CYP450 3A4 Substrate | Non-substrate | 0.6781 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8343 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8468 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9018 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8535 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9203 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9441 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9241 |
| Non-inhibitor | 0.8104 |
| AMES Toxicity | Non AMES toxic | 0.8710 |
| Carcinogens | Carcinogens | 0.7716 |
| Fish Toxicity | High FHMT | 0.9080 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8752 |
| Honey Bee Toxicity | Low HBT | 0.6070 |
| Biodegradation | Not ready biodegradable | 0.9757 |
| Acute Oral Toxicity | III | 0.6173 |
| Carcinogenicity (Three-class) | Non-required | 0.6527 |